Acquired Immunodeficiency Syndrome

Acquired Immunodeficiency Syndrome - most related articles:

- Fragile X syndrome affecting brain cells - 4.2
- Sinus infection rhinosinusitis may lead to toxic shock syndrome - 4.1
- Metabolic syndrome common in psoriasis patients - 4
- MRSA may accompany hospital patients to home - 3.8
- New Down syndrome treatment suggested by US researchers - 3.6
- Zydus Cadila introduces Nudoxa cancer drug - 3.5
- Gastric ulcer medicines increase pneumonia risk in hospitals - 3.4
- AIDS drugs may prevent vaginal transmission of HIV - 3.4
- Restless legs syndrome appears to occur within families - 3.3
- Eye test for early detection of Alzheimer's and Down syndrome - 3.3

Acquired Immunodeficiency Syndrome articles

New drug targets aimed at slowing progression of HIV AIDS
Researchers reveal a mechanism by which the immune system tries to halt the spread of HIV. Harnessing this mechanism may open up new paths for therapeutic research aimed at slowing the virus' progression to AIDS.

Investments for children must be at top of African HIV and AIDS agenda - UNICEF
All children, particularly the poorest and most marginalized, should have access to HIV/AIDS prevention, treatment and care. Against the background of reduced funding for HIV/AIDS activities, partners and decision makers must sustain their contributions to make this world HIV free.

Many US people do not know they have HIV
An estimated 1.2 million people are living with HIV in the United States. Of those, as many as 1 in 5 people (about 240,000) don't know they have HIV.

HIV infections and AIDS related cases reduced
New HIV infections and AIDS-related deaths have fallen to the lowest levels since the peak of the epidemic. New HIV infections were reduced by 21% since 1997, and deaths from AIDS-related illnesses decreased by 21% since 2005.

Marked reduction of HIV among circumcised adult men
Researchers presenting late breaking research on the final day of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) have focussed on new studies in the field of circumcision, pre-exposure prophylaxis (PrEP) and antiretroviral treatment. The IAS 2011 conference has been attended by over 5000 researchers, clinicians and community leaders since Sunday in Rome.

Antiretrovirals significantly reduces HIV transmission to partners
Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by taking oral antiretroviral medicines when their immune systems were relatively healthy, according to findings from a large-scale clinical study.

HIV rates declined in Zimbabwe driven by fear of infection
The big drop in the numbers of people infected with HIV in Zimbabwe is because of mass social change, driven by fear of infection, according to an international study reported in the journal PLoS Medicine.

New research to drive novel ways of treating and preventing HIV
The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference (AIDS 2010) taking place in Vienna, Austria said today.

Pregnancy doubles HIV risk in men
A new study finds that pregnancy is a time when men are at greater risk. In fact, their risk doubles if their partner is both HIV-infected and pregnant.

Bone marrow can harbor HIV infected cells
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. This indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.

Routine HIV screening in community boosts HIV testing
UCSF researchers have that found routinely offering rapid HIV tests to patients in community health centers can significantly increase the number of patients screened for HIV.

PRO 2000 anti HIV gel is ineffective
Pro 2000, a vaginal microbicide gel designed to reduce women's risk of HIV infection, showed no evidence that it reduces the risk of HIV infection, revealed by researchers at Britain's Medical Research Council (MRC).

New HIV vaccine safe and effective in preventing HIV infection
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand.

High HIV infection rate among Soweto Township gays
New research from UCSF examining HIV among men (MSM) in the township of Soweto in South Africa has found that a third of gay-identified men are infected with HIV.

GSK to fight HIV AIDS in Africa
GlaxoSmithKline's CEO Andrew Witty announced a series of new initiatives targeted at improving research, development, and access to HIV/AIDS medicines for children in Sub-Saharan Africa and supporting healthcare for people living with HIV and AIDS.

Combined antiviral and chemotherapy to fight HIV AIDS
HIV-AIDS could be treated through a combination of targeted chemotherapy and current Highly Active Retroviral (HAART) treatments, revealed by researchers.

South Africa's HIV epidemic has stabilised
South Africa's HIV epidemic has levelled off at a prevalence of 10.9% for people aged two years and older, with 5.2 million people estimated to be living with HIV in 2008.

AIDS Action observes HIV vaccine awareness day
Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone.

$1.79 billion to help people living with HIV AIDS
The U.S. Department of Health and Human Services (HHS) announced the release of $1.79 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications.

AIDS patients get benefit from early retroviral use
HIV-positive patients who don't seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on, according to a new multicenter trial led by researchers at the Stanford University School of Medicine.

GSK and Pfizer to create a new HIV company
GlaxoSmithKline plc (GSK) and Pfizer Inc (PFE) announced they have entered into an agreement to create a new world-leading HIV company focused solely on research, development and commercialisation of HIV medicines.

Treating HIV earlier is better
Begin treatment as early as possible: this general common sense rule seems to apply to most diseases except HIV-AIDS, which is only treated once a certain number of immune cells called "CD4+" cells have disappeared.

Male circumcision surely reduces HIV risk
Three recent African trials support male circumcision for reducing the risk of contracting HIV in heterosexual men.

Nadja Benaissa arrested on suspicion of infecting a partner with HIV
Nadja Benaissa - a German pop star singer - was held in Frankfurt because of the suspicion that she had unprotected sexual intercourse with three people in the years 2004 and 2006 without telling them beforehand that she is HIV positive.

Strides received US FDA approval for Lamivudine and Stavudine
Strides Arcolab Limited (Strides) announced that it has received tentative approval from the United States – Food and Drug Administration for one new drug application (NDA) for fixed dose combination of Lamivudine and Stavudine Tablets 150 mg / 30 mg under the expedited review provisions of the President's Emergency Plan for AIDS Relief (PEPFAR).

Education slowing HIV AIDS in sub-Saharan Africa
Increased schooling across sub-Saharan Africa may be lowering new HIV infections among younger adults, according to sociologists, suggesting a shift in a decades-long trend where formal education is considered an AIDS risk factor.

$60 m for tuberculosis and HIV research in South Africa
A groundbreaking partnership between the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN) in South Africa will establish an international research center focused on making major scientific contributions to the worldwide effort to control the devastating co-epidemic of tuberculosis (TB) and HIV and on training a new generation of scientists in Africa.

HIV/AIDS statistics for women and girls startling in US
In US the percentage of new AIDS cases diagnosed among women more than doubled between 1990 and 2005 (the most recent year for which data is available), increasing from 11 percent to more than 26 percent.

Anti HIV gel shows promise in preventing HIV infection in women
An investigational vaginal gel intended to prevent HIV infection in women has demonstrated encouraging signs of success in a clinical trial conducted in Africa and the United States.

New approach to treat HIV, AIDS
Researchers at the Indiana University School of Medicine have identified a potential new target in the war on HIV/AIDS.

Pk antigen in blood raises resistance to HIV
Researchers have discovered a potentially important new resistance factor in the battle against HIV: blood types. An international team of researchers from Canadian Blood Services, The Hospital for Sick Children (SickKids) and Lund University in Sweden have discovered that certain blood types are more predisposed to contracting HIV, while others are more effective at fending it off.

£15 m for South Africa in new struggle against AIDS
South Africa's revitalised drive against AIDS today received a £15 million boost which could help save millions of lives and stop the spread of HIV across the country.

Antiretrovirals with TB treatment reduces mortality in HIV patients
A South African treatment study conducted by researchers in the Department of Epidemiology at the Mailman School of Public Health shows that mortality among TB-HIV co-infected patients can be reduced by a remarkable 55%, if antiretroviral therapy (ART) is provided with TB treatment at the same time.

Indian doctors can't deny HIV+, AIDS patients
India's Supreme Court has approved the Indian Govt.'s direction to all States that doctors in government and private hospitals should not refuse treatment to People Living with HIV/AIDS (PLHA).

34 Acquired Immunodeficiency Syndrome articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.62